FR2377416A1 - Nouveaux antigenes lies au carcinome du sein - Google Patents

Nouveaux antigenes lies au carcinome du sein

Info

Publication number
FR2377416A1
FR2377416A1 FR7800661A FR7800661A FR2377416A1 FR 2377416 A1 FR2377416 A1 FR 2377416A1 FR 7800661 A FR7800661 A FR 7800661A FR 7800661 A FR7800661 A FR 7800661A FR 2377416 A1 FR2377416 A1 FR 2377416A1
Authority
FR
France
Prior art keywords
acs
breast carcinoma
new antigens
incubate
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7800661A
Other languages
English (en)
Other versions
FR2377416B1 (fr
Inventor
Alberto Bartorelli
Roberto Accinni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2377416A1 publication Critical patent/FR2377416A1/fr
Application granted granted Critical
Publication of FR2377416B1 publication Critical patent/FR2377416B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Nouveaux antigènes liés au carcinome du sein Selon l'invention le procédé pour détecter l'ACS circulant dans le sérum sanguin ou le plasma implique d'effectuer les étapes suivantes : a. Ajouter une quantité spécifique d'antisérum anti-ACS à un échantillon sanguin, b. Faire incuber le mélange, c. Ajouter une quantité spécifique d'ACS étiqueté de manière radioactive, d. Faire incuber le mélange e. Séparer les complexes ACS-anti-ACS de l'ACS libre, f. Mesurer la radioactivité soit des complexes soit de l'ACS libre. Application à l'industrie pharmaceutique.
FR7800661A 1977-01-12 1978-01-11 Nouveaux antigenes lies au carcinome du sein Granted FR2377416A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1140/77A GB1598811A (en) 1977-01-12 1977-01-12 Carcinoma-associated antigens

Publications (2)

Publication Number Publication Date
FR2377416A1 true FR2377416A1 (fr) 1978-08-11
FR2377416B1 FR2377416B1 (fr) 1982-08-27

Family

ID=9716885

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800661A Granted FR2377416A1 (fr) 1977-01-12 1978-01-11 Nouveaux antigenes lies au carcinome du sein

Country Status (7)

Country Link
US (1) US4383985A (fr)
JP (1) JPS5388317A (fr)
DE (1) DE2801257A1 (fr)
FR (1) FR2377416A1 (fr)
GB (1) GB1598811A (fr)
IT (1) IT1143800B (fr)
NL (1) NL7800353A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489692A1 (fr) * 1980-09-05 1982-03-12 Univ Ramot Procede de preparation d'un anticorps specifique pour le diagnostic precoce d'une affection maligne, mammaire, et l'anticorps obtenu

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863853A (en) * 1982-04-21 1989-09-05 Bartos Patent Development And Holding Company Limited Method of determining the diagnostic value of monitoring serum-CEA-levels in a carcinoma patient undergoing therapy
US4818709A (en) * 1983-01-21 1989-04-04 Primus Frederick J CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
US4565789A (en) * 1983-04-04 1986-01-21 The United States Of America As Represented By The Department Of Health And Human Services Cell matrix receptor system and use in cancer diagnosis and management
US4529693A (en) * 1983-12-09 1985-07-16 Children's Hospital Medical Center Of Northern California Detecting neoplastic mammary epithelial cells by detecting thioesterase II marker
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
US4571276A (en) * 1984-06-22 1986-02-18 North American Philips Corporation Method for strengthening terminations on reduction fired multilayer capacitors
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4748112A (en) * 1986-03-07 1988-05-31 International Genetic Engineering, Inc. Methods and compositions relating to regression-associated antigens
US4785077A (en) * 1986-05-05 1988-11-15 Scripps Clinic And Research Foundation Substantially pure cytotoxicity triggering factor
US5030621A (en) * 1987-04-23 1991-07-09 Bystryn Jean Claude Shed melanoma antigen compositions
WO1989005306A1 (fr) * 1987-09-16 1989-06-15 International Genetic Engineering, Inc. Procede et compositions relatifs a des antigenes associes a la regression
US5112617A (en) * 1990-03-01 1992-05-12 Criscuolo Pascual A Method for controlling cold symptoms
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
US5281700A (en) * 1992-08-11 1994-01-25 The Regents Of The University Of California Method of recovering endothelial membrane from tissue and applications thereof
US5728579A (en) * 1994-08-11 1998-03-17 President And Fellows Of Harvard College DNA encoding Mat-8
US20030211971A1 (en) * 2001-09-17 2003-11-13 Srivastava Pramod K. Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
WO2005099363A2 (fr) 2004-03-26 2005-10-27 Whitehead Institute For Biomedical Research Methodes de diagnostic, de prevention et de traitement de metastases cancereuses
US8419434B2 (en) * 2008-04-15 2013-04-16 International Business Machines Corporation Interactive recipe preparation using interactive cooking device to communicate with kitchen appliances

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2095728A5 (fr) * 1970-06-01 1972-02-11 Hoffmann La Roche
FR2323147A1 (fr) * 1975-09-03 1977-04-01 Eisai Co Ltd Reactif de diagnose de neoplasme et procede de diagnose de neoplasme

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3410839A (en) * 1964-04-16 1968-11-12 Rand Dev Corp Immunochromatographic partition of soluble antigens
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US3823126A (en) * 1972-05-23 1974-07-09 K Bjorklund Process of separating human cancer antigen proteins by gel filtration
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2095728A5 (fr) * 1970-06-01 1972-02-11 Hoffmann La Roche
FR2323147A1 (fr) * 1975-09-03 1977-04-01 Eisai Co Ltd Reactif de diagnose de neoplasme et procede de diagnose de neoplasme

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1973 *
EXBK/77 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489692A1 (fr) * 1980-09-05 1982-03-12 Univ Ramot Procede de preparation d'un anticorps specifique pour le diagnostic precoce d'une affection maligne, mammaire, et l'anticorps obtenu

Also Published As

Publication number Publication date
DE2801257A1 (de) 1978-07-13
US4383985A (en) 1983-05-17
JPS5388317A (en) 1978-08-03
FR2377416B1 (fr) 1982-08-27
NL7800353A (nl) 1978-07-14
GB1598811A (en) 1981-09-23
IT1143800B (it) 1986-10-22

Similar Documents

Publication Publication Date Title
FR2377416A1 (fr) Nouveaux antigenes lies au carcinome du sein
Tatarinov et al. Development of a radioimmunoassay for pregnancy‐specific beta1‐globulin and its measurement in serum of patients with trophoblastic and non‐trophoblastic tumours
Morgan et al. Studies of an inhibitor of the two antibody immunoassay system
Oroszlan et al. Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-type virus
Nisonoff et al. Heterogeneity of antibody sites in their relative combining affinities for structurally related haptens
Pressman et al. A Comparison of Fluorescein and I131 as Labels for Determining the «in vivo» Localization of Anti-Tissue Antibodies
Petz et al. In vivo metabolism of complement: I. Metabolism of the third component (C′ 3) in acquired hemolytic anemia
Skomedal et al. A radioimmunoassay for cyclic AMP (cAMP) obtained by acetylation of both unlabeled and labeled (3H‐cAMP) ligand, or of unlabeled ligand only
Alexander et al. Analysis for total serum thyroxine by equilibrium competitive protein binding on small, re-usable Sephadex columns
Aizawa et al. Vasculitis and Sjögren's syndrome with IgA-IgG cryoglobulinemia terminating in immunoblastic sarcoma
Lukanidin et al. Antigenic difference between informofers and protein bound to polyribosomal mRNA from rat liver
Ziccardi et al. Modulation of the antigenicity of C1r and C1s by C1 inactivator
Quarles et al. Methods for the identification and characterization of glycoproteins in central and peripheral myelin
Olin et al. Human fetal thyroglobulin: characterization and in vitro biosynthesis studies
Cullen et al. Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments
Feldt-Rasmussen Purification of human thyroglobulin for radioimmunoassay and testing by ultracentrifugal analysis and immunoelectrophoresis
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods
Vriesman et al. Ray γM immunoglobulin: Isolation and some biological characteristics
Kågedal et al. Determination of thyroxine-binding globulin in human serum by single radial immunodiffusion and radioimmunoassay.
YUZURIHA et al. Studies on biotransformation of lysozyme. I. Preparation of labeled lysozyme and its intestinal absorption
von der Decken Labeling with 14C amino acids of albumin-like protein by rat liver ribonucleoprotein particles
Sperti et al. Competitive binding of adenine and nicotinamide–adenine dinucleotide to diphtheria toxin
Cuarón et al. The binding of 131I-triiodothyronine by serum proteins as an in vitro test of thyroid function
Hansson et al. Quantitation of corticosteroid binding globulin (CBG) by steady state polyacrylamide gel electrophoresis (SS-PAGE)
IT1132167B (it) Metodo emolitico per la determinazione in continuo degli anticorpi antistreptolisina o,in campioni di sangue o di siero con impiego di streptolisina o ossidata

Legal Events

Date Code Title Description
ST Notification of lapse